Bronchogen Research Guide

Full name: Bronchogen (Ala-Asp-Glu-Leu Bronchopulmonary Bioregulator)

A short synthetic peptide bioregulator from the Khavinson family targeted at bronchopulmonary (lung/airway) tissue, closely related to Chonluten. Used in the bioregulator community for respiratory support in short repeated courses.

How Bronchogen Works

As a signal peptide (Ala-Asp-Glu-Leu), it is proposed to regulate gene expression in respiratory epithelial tissue, supporting airway lining integrity, antioxidant defense, and local respiratory immune function.

Dosing Protocol

• Typical dose: ~1-2 capsules/day or short injectable courses
• Frequency: Once daily
• Duration: 10-30 day courses
• Route: Oral capsule or subcutaneous

Reported Benefits

• Respiratory/airway support
• Bronchopulmonary tissue maintenance (proposed)
• Local respiratory immune support
• Short course-based protocol

Potential Side Effects

• Limited Western clinical data
• Injection site reactions (injectable)
• Unknown long-term effects

Research Citations

1. Bronchopulmonary peptide bioregulators (2016) - Reported to support respiratory epithelial function and antioxidant defense in regional research studies.

Related Immune Support Compounds

• Thymosin Alpha-1 - Full Profile
• Thymulin - Full Profile
• Lactoferrin - Full Profile
• Beta-Defensin - Full Profile
• TA1 - Full Profile
• Thymalin - Full Profile

View full Bronchogen profile with 3D molecule viewer →